PSU Profiles
Keywords
Last Name
Institution

Michael Glantz

TitleProfessor
InstitutionCollege of Medicine
DepartmentNeurosurgery
Address500 University Drive Hershey PA 17033
Phone7175313828

 Overview 
 overview
PREFERRED TITLE/ROLE:

Physician, Professor

EDUCATION:

Fellowship, Neuro-Oncology, Duke University Medical Center (1990)
Residency, Neurology, SUNY Health Science Center-Stony Brook (New York) (1988)
Internship, Internal Medicine, SUNY Health Science Center-Stony Brook (New York) (1985)
M.D., Brown University School of Medicine (Rhode Island) (1984)



 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Zalatimo O, Zoccoli CM, Patel A, Weston CL, Glantz M. Impact of genetic targets on primary brain tumor therapy: what's ready for prime time? Adv Exp Med Biol. 2013; 779:267-89.
    View in: PubMed
  2. Yamaguchi Y, Shao Z, Sharif S, Du XY, Myles T, Merchant M, Harsh G, Glantz M, Recht L, Morser J, Leung LL. Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. J Biol Chem. 2013 Feb 1; 288(5):3097-111.
    View in: PubMed
  3. Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olson JJ, Olsen JJ, Evans BA, Jensen RL. Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol. 2012 Nov; 110(2):257-64.
    View in: PubMed
  4. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS. Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget. 2011 Oct; 2(10):752-60.
    View in: PubMed
  5. Lin N, Dunn IF, Glantz M, Allison DL, Jensen R, Johnson MD, Friedlander RM, Kesari S. Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg. 2011 Oct; 115(4):730-6.
    View in: PubMed
  6. Alexandru D, Glantz MJ, Kim L, Chamberlain MC, Bota DA. Pulmonary metastases in patients with recurrent, treatment-resistant meningioma: prognosis and identification by ¹¹¹Indium-octreotide imaging. Cancer. 2011 Oct 1; 117(19):4506-11.
    View in: PubMed
  7. Weston CL, Glantz MJ, Connor JR. Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. Fluids Barriers CNS. 2011; 8(1):14.
    View in: PubMed
  8. Mohile NA, Zoccoli CM, Glantz M. Is brain the new bone marrow? Stem cells, cancer, and cognition: a working hypothesis. Neurology. 2011 Mar 29; 76(13):1118-20.
    View in: PubMed
  9. Nagpal S, Glantz MJ, Recht L. Treatment and prevention of secondary CNS lymphoma. Semin Neurol. 2010 Jul; 30(3):263-72.
    View in: PubMed
  10. Glantz MJ, Chamberlain MC, Liu Q, Hsieh CC, Edwards KR, Van Horn A, Recht L. Gender disparity in the rate of partner abandonment in patients with serious medical illness. Cancer. 2009 Nov 15; 115(22):5237-42.
    View in: PubMed
  11. Smith JA, Glantz M. Statistical and trial design considerations in central nervous system prophylaxis studies. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S69-76.
    View in: PubMed
  12. Glantz M, Recht L. The science of prevention: novel strategies for and new insights into central nervous system prophylaxis in patients with cancer. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S1.
    View in: PubMed
  13. Herrlinger U, Glantz M, Schlegel U, Gisselbrecht C, Cavalli F. Should intra-cerebrospinal fluid prophylaxis be part of initial therapy for patients with non-Hodgkin lymphoma: what we know, and how we can find out more. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S25-34.
    View in: PubMed
  14. Glantz M, Kesari S, Recht L, Fleischhack G, Van Horn A. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S17-24.
    View in: PubMed
  15. Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol. 2009 Aug; 36(4 Suppl 2):S35-45.
    View in: PubMed
  16. Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial. Int J Radiat Oncol Biol Phys. 2009 Mar 15; 73(4):1069-76.
    View in: PubMed
  17. Melisko ME, Glantz M, Rugo HS. New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer. Nat Clin Pract Oncol. 2009 Jan; 6(1):25-33.
    View in: PubMed
  18. Chamberlain MC, Glantz MJ. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma. Neurosurgery. 2008 Oct; 63(4):720-6; author reply 726-7.
    View in: PubMed
  19. Lim HY, Thiel E, Glantz MJ. To protect and defend: central nervous system prophylaxis in patients with non-Hodgkin's lymphoma. Curr Opin Oncol. 2008 Sep; 20(5):495-501.
    View in: PubMed
  20. Chamberlain MC, Glantz MJ. CPT-11 for recurrent temozolomide-refractory 1p19q co-deleted anaplastic oligodendroglioma. J Neurooncol. 2008 Sep; 89(2):231-8.
    View in: PubMed
  21. Chamberlain MC, Wei-Tsao DD, Blumenthal DT, Glantz MJ. Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma. Cancer. 2008 May 1; 112(9):2038-45.
    View in: PubMed
  22. Chamberlain MC, Glantz M. Myelomatous meningitis. Cancer. 2008 Apr 1; 112(7):1562-7.
    View in: PubMed
  23. Chamberlain MC, Glantz MJ. Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia. Blood. 2007 Sep 1; 110(5):1698; author reply 1698-9.
    View in: PubMed
  24. Gammon DC, Bhatt MS, Tran L, Van Horn A, Benvenuti M, Glantz MJ. Intrathecal topotecan in adult patients with neoplastic meningitis. Am J Health Syst Pharm. 2006 Nov 1; 63(21):2083-6.
    View in: PubMed
  25. Chamberlain MC, Glantz MJ, Chalmers L, Van Horn A, Sloan AE. Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol. 2007 Mar; 82(1):81-3.
    View in: PubMed
  26. Chamberlain MC, Glantz MJ. Cerebrospinal fluid-disseminated meningioma. Cancer. 2005 Apr 1; 103(7):1427-30.
    View in: PubMed
  27. Chamberlain MC, Recht LD, Glantz M. Regarding "abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial". J Clin Oncol. 2005 Mar 1; 23(7):1587-8; author reply 1588.
    View in: PubMed
  28. Colocci N, Glantz M, Recht L. Prevention and treatment of central nervous system involvement by non-Hodgkin's lymphoma: a review of the literature. Semin Neurol. 2004 Dec; 24(4):395-404.
    View in: PubMed
  29. Glantz M, Chamberlain M, Liu Q, Litofsky NS, Recht LD. Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas. Cancer. 2003 May 1; 97(9):2262-6.
    View in: PubMed
  30. Recht L, Glantz M, Chamberlain M, Hsieh CC. Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol. 2003 Jan; 61(2):127-36.
    View in: PubMed
  31. Katopodis N, Glantz MJ, Kim L, Dafni U, Wu JK, Perides G. Lipid-associated sialoprotein in the cerebrospinal fluid: association with brain malignancies. Cancer. 2001 Aug 15; 92(4):856-62.
    View in: PubMed
  32. Greenberg HS, Chamberlain MC, Glantz MJ, Wang S. Adult medulloblastoma: multiagent chemotherapy. Neuro Oncol. 2001 Jan; 3(1):29-34.
    View in: PubMed
  33. Chamberlain MC, Kormanik PA, Glantz MJ. A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases. Neuro Oncol. 2001 Jan; 3(1):42-5.
    View in: PubMed
  34. Jaeckle KA, Phuphanich S, Bent MJ, Aiken R, Batchelor T, Campbell T, Fulton D, Gilbert M, Heros D, Rogers L, O'Day SJ, Akerley W, Allen J, Baidas S, Gertler SZ, Greenberg HS, LaFollette S, Lesser G, Mason W, Recht L, Wong E, Chamberlain MC, Cohn A, Glantz MJ, Gutheil JC, Maria B, Moots P, New P, Russell C, Shapiro W, Swinnen L, Howell SB. Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer. 2001 Jan; 84(2):157-63.
    View in: PubMed
  35. Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000 May 23; 54(10):1886-93.
    View in: PubMed
  36. McDermott SS, McDermott PF, Skare J, Glantz M, Smith TW, Litofsky NS, Recht LD. Positive CSF HSV PCR in patients with GBM: a note of caution. Neurology. 2000 Feb 8; 54(3):746-9.
    View in: PubMed
  37. Hochberg F, Grossman SA, Mikkelsen T, Glantz M, Fisher JD, Piantadosi S. Lack of efficacy of 9-aminocamptothecin in adults with newly diagnosed glioblastoma multiforme and recurrent high-grade astrocytoma. NABTT CNS Consortium. Neuro Oncol. 2000 Jan; 2(1):29-33.
    View in: PubMed
  38. Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, Maria B, LaFollette S, Schumann GB, Cole BF, Howell SB. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999 Nov; 5(11):3394-402.
    View in: PubMed
  39. Glantz MJ, Cole BF, Recht L, Akerley W, Mills P, Saris S, Hochberg F, Calabresi P, Egorin MJ. High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? J Clin Oncol. 1998 Apr; 16(4):1561-7.
    View in: PubMed
  40. Chamberlain MC, Kormanik P, Glantz M. Recurrent primary central nervous system lymphoma complicated by lymphomatous meningitis. Oncol Rep. 1998 Mar-Apr; 5(2):521-5.
    View in: PubMed
  41. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 1998 Mar 1; 82(5):923-30.
    View in: PubMed
  42. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht LD. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998 Feb 15; 82(4):733-9.
    View in: PubMed
  43. Recht LD, Glantz MJ, Meitner P, Glantz L, Akerley W, Wahlberg L, Saris S, Cole BF. Unexpected in vitro chemosensitivity of malignant gliomas to 4-hydroxyperoxycyclophosphamide (4-HC). J Neurooncol. 1998 Feb; 36(3):201-8.
    View in: PubMed
  44. Glantz MJ, Choy H, Yee L. Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations. Semin Oncol. 1997 Aug; 24(4):477-83.
    View in: PubMed
  45. Glantz MJ, Choy H, Akerley W, Kearns CM, Egorin MJ, Rhodes CH, Cole BF. Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response. Semin Oncol. 1996 Dec; 23(6 Suppl 16):128-35.
    View in: PubMed
  46. Kline JL, Noto RB, Glantz M. Single-photon emission CT in the evaluation of recurrent brain tumor in patients treated with gamma knife radiosurgery or conventional radiation therapy. AJNR Am J Neuroradiol. 1996 Oct; 17(9):1681-6.
    View in: PubMed
  47. Akerley W, Glantz M, Choy H. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer. Semin Oncol. 1996 Oct; 23(5 Suppl 12):14-8.
    View in: PubMed
  48. Glantz MJ, Choy H, Kearns CM, Cole BF, Mills P, Zuhowski EG, Saris S, Rhodes CH, Stopa E, Egorin MJ. Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas. J Clin Oncol. 1996 Feb; 14(2):600-9.
    View in: PubMed
  49. Glantz MJ, Choy H, Kearns CM, Akerley W, Egorin MJ. Weekly, outpatient paclitaxel and concurrent cranial irradiation in adults with brain tumors: preliminary results and promising directions. Semin Oncol. 1995 Oct; 22(5 Suppl 12):26-32.
    View in: PubMed
  50. Glantz MJ, Hall WA, Cole BF, Chozick BS, Shannon CM, Wahlberg L, Akerley W, Marin L, Choy H. Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid-flow status. Cancer. 1995 Jun 15; 75(12):2919-31.
    View in: PubMed
  51. Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC. Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology. 1994 Nov; 44(11):2020-7.
    View in: PubMed
  52. Glantz MJ, Biran H, Myers ME, Gockerman JP, Friedberg MH. The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer. 1994 Jan 1; 73(1):168-75.
    View in: PubMed
  53. Rosenfeld SS, Hoffman JM, Coleman RE, Glantz MJ, Hanson MW, Schold SC. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med. 1992 Apr; 33(4):532-6.
    View in: PubMed
  54. Glantz MJ, Burger PC, Herndon JE, Friedman AH, Cairncross JG, Vick NA, Schold SC. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology. 1991 Nov; 41(11):1741-4.
    View in: PubMed
  55. Glantz MJ, Hoffman JM, Coleman RE, Friedman AH, Hanson MW, Burger PC, Herndon JE, Meisler WJ, Schold SC. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. Ann Neurol. 1991 Apr; 29(4):347-55.
    View in: PubMed
Glantz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_